The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

Health Secretary Robert F. Kennedy Jr. on Wednesday concluded a marathon series of hearings with federal lawmakers, during ...

Starting this autumn, adults aged 50 and older across the European Union may be able to roll up their sleeve just once and ...

The European Commission has approved Moderna’s mCombriax, the first mRNA vaccine to combine protection against influenza and COVID-19 for adults aged 50 and above. The decision follows Phase 3 trial ...

Kennedy acknowledged some HHS cuts are "painful" ...

Results from the phase 4 COMPARE study indicate that Nuvaxovid exhibits a more favorable reactogenicity profile compared with the mNEXSPIKE mRNA vaccine.

FDA expands Caldolor (ibuprofen) injection indication to include postoperative pain in adults and pediatric patients (3 months+).

Pfizer Inc. today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) ...

Approval for children aged 2 to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical trial program CSU is a chronic skin ...